Placebo-Controlled Study to Evaluate the Safety and Efficacy of OPN-305 in Preventing Delayed Renal Graft Function

NCT01794663 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

252

Enrollment

INDUSTRY

Sponsor class

Conditions

Delayed Graft Function

Interventions

DRUG: OPN-305
DRUG: Placebo

Sponsor

Opsona Therapeutics Ltd.